Showing results (6761-6770 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|March 2, 2013
Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategyIndira Padmalayam, Mark SutoCurrent Pharmaceutical Design|March 2, 2013
Insulin resistance, oxidative stress and cardiovascular complications: role of sirtuinsPankaj K Bagul, Sanjay K BanerjeeCurrent Pharmaceutical Design|March 2, 2013
Mitochondrial dysfunction and oxidative stress in insulin resistanceMilagros Rocha, Susana Rovira-Llopis, Celia Bañuls, et al.Current Pharmaceutical Design|April 18, 2013
Cardioprotective effects of sour cherry seed extract (SCSE) on the hypercholesterolemic rabbit heartBela Juhasz, Attila Kertész, Jozsef Balla, et al.Current Pharmaceutical Design|April 18, 2013
Cardiac dysfunction in rats with dietary-induced insulin resistance associated with pharmacologically-induced dyslipidemiaStéphane Tanguy, Marie-Claire Toufektsian, Stéphane Grauzam, et al.Current Pharmaceutical Design|April 18, 2013
The cellular autophagy markers Beclin-1 and LC3B-II are increased during reperfusion in fibrillated mouse heartsGregory Meyer, Attila Czompa, Cyril Reboul, et al.Current Pharmaceutical Design|January 31, 2013
Cytochrome P450 2C19 polymorphism and antiplatelet therapy. Who should really be genotyped?George Kassimis, Eleana F Stavrou, Dimitrios Alexopoulos, et al.Current Pharmaceutical Design|January 31, 2013
Rho as a target to promote repair: translation to clinical studies with cethrinLisa McKerracher, Pierre GuertinCurrent Pharmaceutical Design|January 31, 2013
Pharmacological approaches to chronic spinal cord injuryInge Steuer, Pascal Rouleau, Pierre A GuertinPageof 1,009